Results 91 to 100 of about 1,598,085 (291)
The Problem of Marital Infection in Pulmonary Tuberculosis [PDF]
Ma Jun
openalex +1 more source
PROGNOSIS IN PULMONARY TUBERCULOSIS: THE RESULTS OBTAINED BY ARNETH'S METHOD [PDF]
J. Holroyd
openalex +1 more source
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson+12 more
wiley +1 more source
ABSTRACT In the present investigation, a mathematical model with vaccination, treatment, and environmental impact under real data is presented. Initially, we present the model without any interventions, followed by an examination of its equilibrium points.
Bashir Al‐Hdaibat+4 more
wiley +1 more source
On the Selection of a Climate for Patients with Pulmonary Tuberculosis [PDF]
F. I. KNIGHT
openalex +1 more source
The study explored the clinical characteristics and risk factors of HBoV‐positive severe pneumonia in children. These findings indicate that HBoV can be identified in respiratory samples from children with severe pneumonia, denoting its role as a viral pathogen in hospitalized children with this condition.
Jing Liao+6 more
wiley +1 more source
Discussion upon Climatic Treatment of Pulmonary Tuberculosis versus Home Sanatoria [PDF]
S. G. BONNEY
openalex +1 more source
The final systemic sclerosis patients with interstitial lung disease (SSc‐ILD) progression prediction model was composed of 6 significant risk factors: male, type 2 diabetes mellitus, pericardial effusion, anti‐Ro52, hypoproteinemia, and elevated C‐reactive protein. Our model demonstrated excellent prognostic utility.
Xi Cao+6 more
wiley +1 more source